Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 550 of 808 entries
View as:

Deferoxamine for Iron Overload Before Allogeneic Stem Cell Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT00658411 Org: User:
Start: 08/31/08 End: 12/31/11 Due: 12/31/12

A Pilot of a Microdevice For In Situ Candidate Drug Screening in Cutaneous Lesions of T-Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT04045470 Org: User:
Start: 12/11/19 End: 01/01/27 Due: 01/01/28

Home Transfusion for HEME

Phase: N/A Priority: Normal
NCT ID: NCT05509439 Org: User:
Start: 10/18/24 End: 08/31/25 Due: 08/31/26

RCT of CBD for Anxiety in Advanced Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04482244 Org: User:
Start: 01/19/22 End: 09/18/25 Due: 09/18/26

Crizotinib in Combination With Enzalutamide in Metastatic Castration-resistant Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02207504 Org: User:
Start: 08/31/14 End: 01/03/22 Due: 01/03/23

A Trial of Thalidomide, Celecoxib, Etoposide and Cyclophosphamide in Patients With Relapsed or Progressive Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00165451 Org: User:
Start: 06/30/01 End: 10/31/06 Due: 10/31/07

The Effect of Yoga on Nerve Pain Caused by Chemotherapy (Chemotherapy-Induced Peripheral Neuropathy)

Phase: N/A Priority: Normal
NCT ID: NCT05121558 Org: User:
Start: 10/29/21 End: 10/01/25 Due: 10/01/26

Phase I Trial of the Selective Inhibitor of Nuclear Export, KPT-330, in Relapsed Childhood ALL and AML

Phase: N/A Priority: Normal
NCT ID: NCT02091245 Org: User:
Start: 03/31/14 End: 06/30/25 Due: 06/30/26

Pyrimethamine for the Treatment of Relapsed Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT01066663 Org: User:
Start: 03/31/10 End: 01/31/23 Due: 01/31/24

Bone Marrow Transplantation With Specially Treated Bone Marrow in Treating Patients With Hematologic Cancer That Have Not Responded to Previous Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00005988 Org: User:
Start: 02/29/00 End: 03/08/02 Due: 03/08/03

Rosiglitazone in Treating Patients With Liposarcoma

Phase: N/A Priority: Normal
NCT ID: NCT00004180 Org: User:
Start: 10/31/99 End: 05/31/15 Due: 05/31/16

Acalabrutinib in CNSL

Phase: N/A Priority: Normal
NCT ID: NCT04906902 Org: User:
Start: 08/23/21 End: 01/31/27 Due: 01/31/28

A Study of Docetaxel + ARN-509 in Castration-Resistant Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03093272 Org: User:
Start: 06/23/17 End: 12/31/19 Due: 12/31/20

Refining Local-Regional Therapy for IBC

Phase: N/A Priority: Normal
NCT ID: NCT04636710 Org: User:
Start: 06/02/21 End: 12/01/28 Due: 12/01/29

Systematic Hereditary Pancreatic Cancer Risk Assessment and Implications for Personalized Therapy

Phase: N/A Priority: Normal
NCT ID: NCT03060720 Org: User:
Start: 02/24/17 End: 02/28/26 Due: 02/28/27

Obinutuzumab in cGVHD After Allogeneic Peripheral Blood Stem Cell Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT02867384 Org: User:
Start: 11/29/16 End: 11/14/24 Due: 11/14/25

Sexual Health and Rehabilitation Online (SHAREonline)

Phase: N/A Priority: Normal
NCT ID: NCT06458049 Org: User:
Start: 02/19/25 End: 05/31/27 Due: 05/31/28

Phase I Study of the Oral PI3kinase Inhibitor BKM120 or BYL719 and the Oral PARP Inhibitor Olaparib in Patients With Recurrent Triple Negative Breast Cancer or High Grade Serous Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01623349 Org: User:
Start: 09/30/12 End: 12/31/20 Due: 12/31/21

A Phase I Study Of Panobinostat/Lenalidomide/Bortezomib/Dex for Relapsed And Relapsed/Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT01965353 Org: User:
Start: 10/31/13 End: 09/30/21 Due: 09/30/22

Letrozole in Preventing Breast Cancer in Postmenopausal Women

Phase: N/A Priority: Normal
NCT ID: NCT00090857 Org: User:
Start: 02/28/02 End: 03/31/13 Due: 03/31/14

Merestinib In Non-Small Cell Lung Cancer And Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02920996 Org: User:
Start: 11/11/16 End: 10/31/23 Due: 10/31/24

Individualizing Surveillance Mammography for Older Breast Cancer Survivors

Phase: N/A Priority: Normal
NCT ID: NCT03865654 Org: User:
Start: 05/16/19 End: 07/01/21 Due: 07/01/22

PET/CT-Assessment of Liver Tumor Ablation

Phase: N/A Priority: Normal
NCT ID: NCT02018107 Org: User:
Start: 01/31/14 End: 02/16/19 Due: 02/16/20

Study of Clofarabine in Patients With Recurrent or Refractory Langerhans Cell Histiocytosis and LCH-related Disorders

Phase: N/A Priority: Normal
NCT ID: NCT02425904 Org: User:
Start: 05/31/15 End: 01/31/26 Due: 01/31/27

Docetaxel in Combination With Zactima (ZD6474) in Patients With Locally Advanced Squamous Cell Carcinoma of the the Head and Neck

Phase: N/A Priority: Normal
NCT ID: NCT00459043 Org: User:
Start: 03/31/07 End: 02/29/12 Due: 02/28/13